Reviva announces grant of european patent covering use of brilaroxazine for the treatment of pulmonary hypertension

- patent covers brilaroxazine use for treating pulmonary hypertension (ph), pulmonary arterial hypertension (pah) in any patients including treating ph in patients with chronic obstructive pulmonary disease (copd) or sickle cell disease (scd)

RVPH Ratings Summary

RVPH Quant Ranking